Certifies and grades diamonds, gemstones and jewelry for authenticity and quality, mainly for Indian and global trade.
Certifies and grades diamonds, gemstones and jewelry for authenticity and quality, mainly for Indian and global trade.
Charges a fee for each stone or jewellery piece it grades and certifies, with the report acting as a document that buyer and seller both trust, so income follows the volume of gems passing through the trade, including fast-growing lab-grown diamonds.
In one line: India's GIA.
Moat: narrow (brand, scale). Globally recognized grading brand trusted by jewelers; switching certifiers risks buyer confidence.
Headquarters: Mumbai, India · Employees: 1,345
Size International Gemological Institute (IGIL.NS) is an India Industrials company (Miscellaneous Commercial Services) with a market value of $2.05B, the 370th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹444.10 on 18 Nov 2026.
Performance Over six months the shares gained 33.5%, against -9.3% for the median peer and +3.8% for the India market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue grew 21.4% over the last twelve months (peer median +16.7%); the operating margin is 57.7% (peer median 12.7%).
Valuation It trades at 26.0× forward earnings against a peer median of 18.3× (7th most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +38%, so the hurdle is -21 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 34.8 points above its cost of capital (12.1% WACC).
Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹14.6B | ₹12.8B | ₹10.5B | ₹8.98B | ₹4.91B |
| Revenue growth | — | +21% | +17% | +83% | — |
| Gross profit | ₹10.8B | ₹8.99B | ₹7.42B | ₹6.16B | ₹3.88B |
| EBITDA | ₹8.96B | ₹7.88B | ₹6.17B | ₹5.04B | ₹3.38B |
| Net income | ₹6.66B | ₹5.69B | ₹4.27B | ₹3.31B | ₹2.42B |
| Free cash flow | n/a | ₹5.99B | ₹3.61B | ₹2.51B | ₹1.87B |
| Capital expenditure | n/a | ₹821M | ₹395M | ₹550M | ₹111M |
| Total debt | ₹1.50B | ₹1.43B | ₹1.45B | ₹1.51B | ₹267M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | IGIL.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +37.9% | -1.1% | highest of 21 |
| 6-month return | +33.5% | -9.3% | 3rd highest of 21 |
| Distance from 52-week high | -2.1% | -31.4% | highest of 21 |
| Revenue growth (TTM) | +21.4% | +16.7% | 8th highest of 19 |
| Operating margin | 57.7% | 12.7% | highest of 20 |
| Forward P/E | 26.0× | 18.3× | 7th most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 16.3% | 19.2% | 7th least demanding of 14 |
| Growth delivered (Del g) | +37.6% | +10.5% | 2nd highest of 13 |
| Hurdle (Req g minus delivered) | -21.3 pp | -9.2 pp | 3rd least demanding of 13 |
| ROIC minus cost of capital | +34.8 pp | +0.4 pp | highest of 19 |
| EV / EBITDA | 20.9× | 11.5× | 2nd most expensive of 11 |
| Net debt / EBITDA | -0.5× | 0.6× | 2nd least indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| International Gemological Institute IGIL.NS | India | $2.05B | +33% | +21% | 58% | 26.0× | 16.3% | +37.6% |
| Firstsource Solutions FSL.NS | India | $2.04B | +13% | +20% | 12% | 20.4× | 19.2% | +13.5% |
| Suzhou Nanomicro Technology 688690.SS | China | $2.08B | -1% | +26% | 25% | 51.5× | 33.2% | +35.2% |
| Biocytogen Pharmaceuticals (Beijing) 688796.SS | China | $2.09B | -33% | +40% | 24% | 73.0× | 31.0% | +41.1% |
| Sigurd Microelectronics 6257.TW | Taiwan | $2.10B | -28% | +18% | 24% | 11.3× | n/a | n/a |
| TIC Solutions TIC | United States | $2.15B | +14% | +39% | -1% | n/a | 32.6% | n/a |
| Heron Neutron Medical 7799.TW | Taiwan | $2.15B | +56% | n/a | -5,319% | 355.2× | n/a | n/a |
| Ardentec 3264.TWO | Taiwan | $2.17B | -26% | +32% | 30% | 11.3× | n/a | n/a |
| Syngene International SYNGENE.NS | India | $1.88B | -8% | -6% | 13% | 70.7× | 36.4% | +11.4% |
| Jiangsu Guotai International 002091.SZ | China | $1.87B | -15% | +7% | 6% | 9.7× | -21.2% | +5.5% |
| Insperity NSP | United States | $1.86B | +55% | +2% | 0% | 19.6× | 19.4% | +9.7% |
| Sagility SAGILITY.NS | India | $2.26B | +7% | +28% | 18% | 17.0× | 11.2% | +19.5% |
| Hui Lyu Ecological Technology Groups 001267.SZ | China | $2.28B | -68% | +90% | 10% | 133.5× | n/a | n/a |
| KWS SAAT SE & Co KGaA KWS.DE | Germany | $2.30B | -11% | -1% | 13% | 12.7× | -6.0% | +4.4% |
| China Automotive Engineering Research Institute 601965.SS | China | $2.31B | -11% | +12% | 24% | 13.8× | -4.7% | +7.9% |
| Prosegur Compania de Seguridad PSG.MC | Spain | $1.82B | +10% | +4% | 6% | 12.2× | -3.7% | +6.7% |
| CECEP Environmental Protection 300140.SZ | China | $2.37B | -23% | -2% | 23% | n/a | -1.9% | +26.0% |
| Shanghai GenTech 688596.SS | China | $2.37B | +4% | +4% | 2% | 68.2× | n/a | n/a |
| Beijing Orient EcoEnergy 002310.SZ | China | $1.75B | -25% | +35% | 12% | n/a | 36.0% | -47.6% |
| Hoist Finance HOFI.ST | Sweden | $1.75B | +20% | +16% | 30% | 12.2× | n/a | n/a |
| Xi'an Taijin New Energy & Materials Sci-Tech 688813.SS | China | $1.73B | -42% | n/a | n/a | n/a | n/a | n/a |